Holen Sie sich die Stockscreener-App
116.84
3.17%
-3.82
Handel nachbörslich:
116.85
0.010
+0.01%
Schlusskurs vom Vortag:
$120.66
Offen:
$120.53
24-Stunden-Volumen:
485.41K
Relative Volume:
0.82
Marktkapitalisierung:
$3.84B
Einnahmen:
$787.85M
Nettoeinkommen (Verlust:
$-27.78M
KGV:
-134.67
EPS:
-0.8676
Netto-Cashflow:
$18.75M
1W Leistung:
-1.96%
1M Leistung:
+1.39%
6M Leistung:
-33.73%
1J Leistung:
-15.15%
1-Tages-Spanne:
$115.56
$122.78
1-Wochen-Bereich:
$113.85
$128.77
52-Wochen-Spanne:
$112.31
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Holdings Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
116.84 | 3.97B | 787.85M | -27.78M | 18.75M | -0.8676 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-09-23 | Eingeleitet | Evercore ISI | In-line |
| 2025-08-20 | Eingeleitet | BofA Securities | Buy |
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Holdings Inc Aktie (IRTC) Neueste Nachrichten
IRTC (NASDAQ) director files Form 144 to sell 5,312 shares via exercise - Stock Titan
Net current asset value per share of iRhythm Holdings, Inc. – LSE:0A7L - TradingView
Will Strong Q1 Results And New Zio Data Change iRhythm Holdings' (IRTC) Narrative - Sahm
Here's why you should retain IRTC stock in your portfolio for now - MSN
IRTC SEC FilingsiRhythm Holdings, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
iRhythm Holdings, Inc. (IRTC) reports Q1 loss, tops revenue estimates - MSN
Sands Capital (IRTC) files Schedule 13G/A amendment on iRhythm ownership - Stock Titan
iRhythm stock rises on Medicare coverage update (IRTC:NASDAQ) - Seeking Alpha
Wall Street analysts predict a 57.21% upside in iRhythm Hldgs (IRTC): Here's what you should know - MSN
iRhythm Holdings CTO Lawrence Lee sells $122,491 in stock By Investing.com - Investing.com Nigeria
iRhythm Holdings CTO Lawrence Lee sells $122,491 in stock - Investing.com
iRhythm (NASDAQ: IRTC) CTO sells 1,014 shares to cover RSU tax obligations - Stock Titan
Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's What You Should Know - Yahoo Finance
Why iRhythm Holdings, Inc. (IRTC) is a top momentum stock for the long term - MSN
iRhythm Holdings, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:IRTC) 2026-05-04 - Seeking Alpha
IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised - Zacks Investment Research
Citi Maintains IRhythm Technologies(IRTC.US) With Buy Rating, Raises Target Price to $157 - Moomoo
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Is A 52.44% Upside Just Around The Corner? - DirectorsTalk Interviews
US$184: That's What Analysts Think iRhythm Holdings, Inc. (NASDAQ:IRTC) Is Worth After Its Latest Results - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Rating Increased to Buy at Wall Street Zen - MarketBeat
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC) and Apogee Therapeutics (APGE) - The Globe and Mail
iRhythm Holdings, Inc. Q1 2026 Financial Results and Forward-Looking Statements – Form 10-Q Highlights - Minichart
IRTC Maintained by JP Morgan -- Price Target Lowered to $175 - GuruFocus
IRTC Maintained by Canaccord Genuity -- Price Target Lowered to $180 - GuruFocus
IRTC Maintained by Wells Fargo -- Price Target Lowered to $180 - GuruFocus
JPMorgan Chase & Co. Has Lowered Expectations for iRhythm Technologies (NASDAQ:IRTC) Stock Price - MarketBeat
IRTC Maintained by Needham -- Price Target Raised to $255 - GuruFocus
IRTC Maintained by Evercore ISI Group -- Price Target Lowered to $160 - GuruFocus
Oppenheimer Adjusts Price Target on iRhythm Technologies to $185 From $225, Maintains Outperform Rating - marketscreener.com
iRhythm Technologies (NASDAQ:IRTC) Shares Down 6.5% Following Analyst Downgrade - MarketBeat
Wells Fargo & Company Has Lowered Expectations for iRhythm Technologies (NASDAQ:IRTC) Stock Price - MarketBeat
Q1 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
iRhythm Holdings Inc (IRTC) Q1 2026 Earnings Call Highlights: St - GuruFocus
Truist Cuts PT on iRhythm Technologies (IRTC) as Part of Fiscal Q1 Results Preview in MedTech - Insider Monkey
iRhythm forecasts 2026 revenue of $875M-$885M while targeting 12%-13% adjusted EBITDA margin - MSN
iRhythm Holdings Announces First Quarter 2026 Financial Results - The Manila Times
IRhythm Technologies Q1 2026 earnings preview - MSN
IRTC SWOT Analysis: Growth Potential Amid Financial Challenges R - GuruFocus
Transcript : IRhythm Holdings, Inc., Q1 2026 Earnings Call, Apr 30, 2026 - marketscreener.com
Why The Narrative Around iRhythm Holdings (IRTC) Is Shifting After Valuation And DOJ Updates - Yahoo Finance
iRhythm Technologies (NASDAQ:IRTC) Announces Quarterly Earnings Results - MarketBeat
Is iRhythm Holdings (IRTC) 23.9% Undervalued After Q1 2026 Beat? - GuruFocus
iRhythm Holdings, Inc. (IRTC) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
IRhythm Q1 Adjusted Loss Narrows, Revenue Rises - marketscreener.com
(IRTC) iRhythm Expects 2026 Revenue Range $875 Million-$885 Million, vs. FactSet Est of $876.2 Million - marketscreener.com
iRhythm Holdings (NASDAQ: IRTC) grows Q1 2026 sales and turns Adjusted EBITDA positive - Stock Titan
iRhythm Holdings Inc (NASDAQ:IRTC) Beats Q1 Estimates, Raises Guidance, Shares Surge - ChartMill
iRhythm (NASDAQ:IRTC) Posts Better-Than-Expected Sales In Q1 CY2026 - Barchart.com
Earnings Flash (IRTC) iRhythm Holdings, Inc. Posts Q1 Adjusted Loss $0.35 per Share, vs. FactSet Est of $-0.62 - marketscreener.com
Finanzdaten der Irhythm Holdings Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):